635 per cent returns in this high ROE and high ROCE multibagger stock; Board announces bonus shares!

The stock gave multibagger returns of 635 per cent from its 52-week low of Rs 140 per share.

Jeena Sikho Lifecare Limited informed that the Board of Directors of the company has approved bonus shares in the ratio of 4:5, i.e., 4 bonus equity shares (fully paid‐up) of Rs 10 each for every 5 existing equity shares of Rs 10 each, held by the shareholders in the company, as on the record date. The process of issuance of bonus shares shall be completed within the period of two months from the date of the Board Meeting i.e., by November 24, 2023.

Pre-Bonus Issue – Issued and Paid Share Capital: Rs 13,81,11,920 divided into 1,38,11,192 equity shares of Rs 10 each.

Post Bonus Issue – Issued and Paid Share Capital: Rs 24,86,01,460 divided into 2,48,60,146 equity shares of Rs 10 each (Subject to the adjustment due to fractional entitlement of bonus shares, as per the shareholder’s list as on the record date to be fixed for the Board Meeting).
Jeena Sikho Lifecare is one of the leading Ayurvedic healthcare system providers in India. The company has been providing healthcare services for the last ten years. The company has a market cap of Rs 1,367.31 crore. According to the half-yearly results, the net sales increased by 56 per cent to Rs 117 crore and net profit skyrocketed by 360 per cent to Rs 23 crore in H2FY23 compared to H2FY22. In annual results, the net sales increased by 40 per cent to Rs 204 crore and net profit skyrocketed by 209 per cent to Rs 34 crore in FY23 compared to FY22.

On Tuesday, shares of Jeena Sikho Lifecare Ltd plunged 2.94 per cent to Rs 990 per share with an intraday high of Rs 1,030 per share and an intraday low of Rs 980.50.

The shares of the company have an ROE of 41.1 per cent and an ROCE of 52.7 per cent. The stock gave multibagger returns of 635 per cent from its 52-week low of Rs 140 per share. The stock falls under the SME segment with a lot size of 1,000 shares and investors should keep an eye on this stock.

Disclaimer: The article is for informational purposes only and not investment advice.